Literature DB >> 7507180

Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors.

W A O'Brien1, A Namazi, H Kalhor, S H Mao, J A Zack, I S Chen.   

Abstract

Human immunodeficiency virus type 1 infection of mononuclear phagocytes has been implicated in disease manifestations, but postentry viral replication events in these cells have not been well characterized. Productive infection of activated T cells is associated with cell proliferation and accumulation of full-length viral DNA within 6 h. In infected, nondividing quiescent peripheral blood lymphocytes, reverse transcription is aborted prior to full-length viral DNA formation. For nondividing, cultured mononuclear phagocytes, we now report a third pattern of reverse transcription with relatively slow kinetics, in which full-length viral DNA did not accumulate until 36 to 48 h. The reverse transcription rate in mononuclear phagocytes could be accelerated by addition of exogenous nucleotide precursors, but still not to the rate seen in activated T cells. These results indicate that substrate limitations in mononuclear phagocytes slow but do not arrest human immunodeficiency virus type 1 reverse transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507180      PMCID: PMC236573     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA.

Authors:  H E Varmus; T Padgett; S Heasley; G Simon; J M Bishop
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

2.  Kinetics of synthesis, structure and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells.

Authors:  H E Varmus; S Heasley; H J Kung; H Oppermann; V C Smith; J M Bishop; P R Shank
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus.

Authors:  E Gilboa; S Goff; A Shields; F Yoshimura; S Mitra; D Baltimore
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

6.  In vitro synthesis of infectious transforming DNA by the avian sarcoma virus reverse transcriptase.

Authors:  C H Clayman; E Mosharrafa; A J Faras
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

7.  Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts.

Authors:  L R Boone; A M Skalka
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

8.  Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats.

Authors:  O Narayan; J S Wolinsky; J E Clements; J D Strandberg; D E Griffin; L C Cork
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

9.  Establishment of infection by spleen necrosis virus: inhibition in stationary cells and the role of secondary infection.

Authors:  I S Chen; H M Temin
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

10.  In vitro synthesis of infectious DNA of murine leukaemia virus.

Authors:  E Rothenberg; D Smotkin; D Baltimore; R A Weinberg
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

View more
  91 in total

1.  Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription.

Authors:  J K Pfeiffer; R S Topping; N H Shin; A Telesnitsky
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Tat is required for efficient HIV-1 reverse transcription.

Authors:  D Harrich; C Ulich; L F García-Martínez; R B Gaynor
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

3.  Dynamics of HIV-1 recombination in its natural target cells.

Authors:  David N Levy; Grace M Aldrovandi; Olaf Kutsch; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

4.  Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.

Authors:  Grant Trobridge; David W Russell
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages.

Authors:  Arevik Mosoian; Avelino Teixeira; Anthony A High; Robert E Christian; Donald F Hunt; Jeffrey Shabanowitz; Xinyan Liu; Mary Klotman
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells.

Authors:  Dimitrios N Vatakis; Gregory Bristol; Thomas A Wilkinson; Samson A Chow; Jerome A Zack
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.

Authors:  Theodore C Pierson; Yan Zhou; Tara L Kieffer; Christian T Ruff; Christopher Buck; Robert F Siliciano
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle.

Authors:  R A Fouchier; M Brouwer; N A Kootstra; H G Huisman; H Schuitemaker
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.

Authors:  D L Lichtenstein; K E Rushlow; R F Cook; M L Raabe; C J Swardson; G J Kociba; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Kinetics of lentiviral vector transduction in human CD34(+) cells.

Authors:  Naoya Uchida; Rashidah Green; Josiah Ballantine; Luke P Skala; Matthew M Hsieh; John F Tisdale
Journal:  Exp Hematol       Date:  2015-10-21       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.